Turkey is a prominent destination for prostate cancer treatment, with hospitals accredited by the Joint Commission International (JCI). Leading centers like Anadolu Medical Center, Memorial Şişli Hospital, and Hisar Hospital Intercontinental offer robotic-assisted prostatectomy, focal therapy, HIFU, and SBRT. Prostate cancer survival rates in Turkey reach up to 98% for early-stage cases, aided by advanced diagnostics and personalized plans.
Anadolu Medical Center, affiliated with Johns Hopkins Medicine, is known for high care standards and comprehensive oncology services. Memorial Şişli Hospital, the first JCI-accredited in Turkey, boasts a 90% success rate in organ transplants and leads in oncology, attracting patients from 92 countries. Hisar Hospital Intercontinental, also JCI-accredited, excels in oncology and radiotherapy, serving a vast international patient base.